AB Science S.A. ABSCF
1.12 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
2.70 Day range 2.70
1.12 52-week range 2.70
- YTD
- -22.76%
- 1 year
- -11.11%
- Market cap
- 108.11M
- EPS (ttm)
- -0.03
- YTD return
- -22.76%
- 1-year return
- -11.11%
- Volume
- 1.45K
- Open
- 2.70
- Previous close
- 1.12
- Day's range
- 2.70 – 2.70
- 52-week range
- 1.12 – 2.70
2Y +0.12 (+12.00%)
News
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS 
AB Science : Stonegate Capital Partners updates its coverage of AB Science's stock with a target price of EUR 4.25 per share 
AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share 
AB Science reports its revenues for the year 2025 and provides an update on its activities 
AB Science announces the successful completion of a EUR 3.2 million private placement 
AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors 
AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients 
AB Science provides an update on its clinical development program. 
AB Science announces the identification of a plasma biomarker that indicates the activity of masitinib in treating ALS 
Stonegate Capital Partners Initiates Coverage on AB Science S.A. (AB)
Your note
Sign in to keep a note on ABSCF — it syncs with the Stock Master app.